Evidence map›Paper›PMID 32363985›Full record

ReviewThe Journal of international medical research2020

Hepatocellular carcinoma and multiple myeloma with elevated globulin: a case report and literature review.

Ling Xu, Wei Yang, Ye-Fei Shu, Xiao-Feng Xu

Open access · goldAbstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ling XuDepartment of Hematology, HangZhou Red Cross Hospital, Hangzhou, Zhejiang, China.
Wei YangDepartment of Hematology, HangZhou Red Cross Hospital, Hangzhou, Zhejiang, China.
Ye-Fei ShuDepartment of Hematology, HangZhou Red Cross Hospital, Hangzhou, Zhejiang, China.ORCID https://orcid.org/0000-0002-1625-0421
Xiao-Feng XuDepartment of Hematology, HangZhou Red Cross Hospital, Hangzhou, Zhejiang, China.ORCID https://orcid.org/0000-0003-1590-681X
Hangzhou Red Cross Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 60-year-old male patient presented with a serum α-fetoprotein (AFP) level of 2940.5 ng/mL accompanied by a significant increase in serum globulin. Hepatitis B virus (HBV) DNA was 2.85 × 10

Indexed as

alpha-FetoproteinsAntineoplastic Combined Chemotherapy ProtocolsBone MarrowCarcinoma, HepatocellularDiagnosis, DifferentialDNA, ViralFatal OutcomeHepatitis B, ChronicHepatitis B virusHumansLiver NeoplasmsMagnetic Resonance ImagingMaleMiddle AgedMultiple MyelomaNeoplasm Recurrence, LocalAFP protein, humanalpha-FetoproteinsDNA, ViralTenofovirdisseminated intravascular coagulationGlobulinhepatitis B virushepatocellular carcinomamultiple myelomaα-fetoprotein

Identifiers

PMID32363985
PMCPMC7218943
OpenAlexW3021485960

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.